SETD2 deficiency impairs β-catenin destruction complex to facilitate renal cell carcinoma formation

作者: Hanyu Rao , Xiaoxue Li , Min Liu , Jing Liu , Wenxin Feng

DOI: 10.1101/2020.07.13.200220

关键词:

摘要: Clear cell renal carcinoma (ccRCC) is a largely incurable disease that highly relevant to epigenetic regulation including histone modification and DNA methylation. SET domain-containing 2 (SETD2) predominant methyltransferase catalyzing the trimethylation of H3 Lysine 36 (H3K36me3) its mutations are clear (ccRCC). However, physiology role in ccRCC remains unexplored. Here we report Setd2 deletion impairs {beta}-catenin destruction complex facilitate formation c-MYC-generated polycystic kidney (PKD) model, which can be relieved by an inhibitor {beta}-catenin-responsive transcription. Clinically, SETD2 loss widely observed samples, negatively correlated with expression some members complex, but positively activation Wnt/{beta}-catenin signaling. Our findings thus highlight previously unrecognized SETD2-mediated H3K36me3 pathway ccRCC. SummaryOur for first time reveal shed light on molecular mechanisms underlying disorders.

参考文章(58)
T H Ho, I Y Park, H Zhao, P Tong, M D Champion, H Yan, F A Monzon, A Hoang, P Tamboli, A S Parker, R W Joseph, W Qiao, K Dykema, N M Tannir, E P Castle, R Nunez-Nateras, B T Teh, J Wang, C L Walker, M-C Hung, E Jonasch, High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma Oncogene. ,vol. 35, pp. 1565- 1574 ,(2016) , 10.1038/ONC.2015.221
Emelyn H. Shroff, Livia S. Eberlin, Vanessa M. Dang, Arvin M. Gouw, Meital Gabay, Stacey J. Adam, David I. Bellovin, Phuoc T. Tran, William M. Philbrick, Adolfo Garcia-Ocana, Stephanie C. Casey, Yulin Li, Chi V. Dang, Richard N. Zare, Dean W. Felsher, MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 112, pp. 6539- 6544 ,(2015) , 10.1073/PNAS.1507228112
Seung Hyeok Han, Laura Malaga-Dieguez, Frank Chinga, Hyun Mi Kang, Jianling Tao, Kimberly Reidy, Katalin Susztak, Deletion of Lkb1 in Renal Tubular Epithelial Cells Leads to CKD by Altering Metabolism Journal of The American Society of Nephrology. ,vol. 27, pp. 439- 453 ,(2016) , 10.1681/ASN.2014121181
Xiaofan Zhu, Fuhong He, Huimin Zeng, Shaoping Ling, Aili Chen, Yaqin Wang, Xiaomei Yan, Wei Wei, Yakun Pang, Hui Cheng, Chunlan Hua, Yue Zhang, Xuejing Yang, Xin Lu, Lihua Cao, Lingtong Hao, Lili Dong, Wei Zou, Jun Wu, Xia Li, Si Zheng, Jin Yan, Jing Zhou, Lixia Zhang, Shuangli Mi, Xiaojuan Wang, Li Zhang, Yao Zou, Yumei Chen, Zhe Geng, Jianmin Wang, Jianfeng Zhou, Xin Liu, Jianxiang Wang, Weiping Yuan, Gang Huang, Tao Cheng, Qian-fei Wang, Identification of functional cooperative mutations of SETD2 in human acute leukemia. Nature Genetics. ,vol. 46, pp. 287- 293 ,(2014) , 10.1038/NG.2894
N Kanu, E Grönroos, P Martinez, R A Burrell, X Yi Goh, J Bartkova, A Maya-Mendoza, M Mistrík, A J Rowan, H Patel, A Rabinowitz, P East, G Wilson, C R Santos, N McGranahan, S Gulati, M Gerlinger, N J Birkbak, T Joshi, L B Alexandrov, M R Stratton, T Powles, N Matthews, P A Bates, A Stewart, Z Szallasi, J Larkin, J Bartek, C Swanton, SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair Oncogene. ,vol. 34, pp. 5699- 5708 ,(2015) , 10.1038/ONC.2015.24
Tarjei S. Mikkelsen, Manching Ku, David B. Jaffe, Biju Issac, Erez Lieberman, Georgia Giannoukos, Pablo Alvarez, William Brockman, Tae-Kyung Kim, Richard P. Koche, William Lee, Eric Mendenhall, Aisling O’Donovan, Aviva Presser, Carsten Russ, Xiaohui Xie, Alexander Meissner, Marius Wernig, Rudolf Jaenisch, Chad Nusbaum, Eric S. Lander, Bradley E. Bernstein, Genome-wide maps of chromatin state in pluripotent and lineage-committed cells Nature. ,vol. 448, pp. 553- 560 ,(2007) , 10.1038/NATURE06008
Yuanliang Zhang, Shugao Xie, Yan Zhou, Yinyin Xie, Ping Liu, Mingming Sun, Huasheng Xiao, Ying Jin, Xiaojian Sun, Zhu Chen, Qiuhua Huang, Saijuan Chen, H3K36 Histone Methyltransferase Setd2 Is Required for Murine Embryonic Stem Cell Differentiation toward Endoderm Cell Reports. ,vol. 8, pp. 1989- 2002 ,(2014) , 10.1016/J.CELREP.2014.08.031
Adam M. Fontebasso, Jeremy Schwartzentruber, Dong-Anh Khuong-Quang, Xiao-Yang Liu, Dominik Sturm, Andrey Korshunov, David T. W. Jones, Hendrik Witt, Marcel Kool, Steffen Albrecht, Adam Fleming, Djihad Hadjadj, Stephan Busche, Pierre Lepage, Alexandre Montpetit, Alfredo Staffa, Noha Gerges, Magdalena Zakrzewska, Krzystof Zakrzewski, Pawel P. Liberski, Peter Hauser, Miklos Garami, Almos Klekner, Laszlo Bognar, Gelareh Zadeh, Damien Faury, Stefan M. Pfister, Nada Jabado, Jacek Majewski, Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas Acta Neuropathologica. ,vol. 125, pp. 659- 669 ,(2013) , 10.1007/S00401-013-1095-8
Chenchen Feng, Yang Sun, Guanxiong Ding, Zhong Wu, Haowen Jiang, Lujia Wang, Qiang Ding, Hui Wen, PI3Kβ Inhibitor TGX221 Selectively Inhibits Renal Cell Carcinoma Cells with Both VHL and SETD2 mutations and Links Multiple Pathways Scientific Reports. ,vol. 5, pp. 9465- 9465 ,(2015) , 10.1038/SREP09465
Stephen B. Baylin, Peter A. Jones, A decade of exploring the cancer epigenome — biological and translational implications Nature Reviews Cancer. ,vol. 11, pp. 726- 734 ,(2011) , 10.1038/NRC3130